Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC
This engaging, expert panel highlights the most recent data with NSCLC disparities and how clinicians can properly address these gaps. This program also reviews how clinicians can help increase the enrollment of minorities in NSCLC clinical trials as well as to facilitate overall minority NSCLC care coordination.
Precision Medicine for All: Strategies for Meaningful and Sustainable Improvements to Reduce Health Disparities in NSCLC
Clinical CommentaryDespite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how to assess opportunities to increase referral of minority patients to clinical trials and how to optimize overall care coordination among minority patients with NSCLC.
Faculty: Narjust Duma, MD; Sally Lemke DNP, WHNP-BC
Release Date:
Expiration Date: April 25, 2023
CME/CE is no longer available for this activity
